Gene · 9294
Papers2,171
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,171
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional roles of sphingolipids in immunity and their implication in disease. | Exp Mol Med | 2023 | 37258585 | PubTator, text mining | PubMed |
| Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity. | Front Immunol | 2023 | 37256134 | PubTator, text mining | PubMed |
| Sphingosine-1-phosphate derived from PRP-Exos promotes angiogenesis in diabetic wound healing via the S1PR1/AKT/FN1 signalling pathway. | Burns Trauma | 2023 | 37251708 | PubTator, text mining | PubMed |
| SARS-CoV-2 induced HDL dysfunction may affect the host's response to and recovery from COVID-19. | Immun Inflamm Dis | 2023 | 37249296 | PubTator, text mining | PubMed |
| Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease. | Nutrients | 2023 | 37242293 | PubTator, text mining | PubMed |
| Sphingosine-1-Phosphate Signaling in Cardiovascular Diseases. | Biomolecules | 2023 | 37238688 | PubTator, text mining | PubMed |
| Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease. | Antioxidants (Basel) | 2023 | 37237968 | PubTator, text mining | PubMed |
| Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors. | Immunooncol Technol | 2023 | 37234285 | PubTator, text mining | PubMed |
| Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma. | Int J Immunopathol Pharmacol | 2023 | 37232164 | PubTator, text mining | PubMed |
| Intrahepatic cholestasis of pregnancy worsening perinatal depressive tendency: A follow-up study from the second trimester to the sixth week postpartum. | Heliyon | 2023 | 37215870 | PubTator, text mining | PubMed |
| The Hylemon-Björkhem pathway of bile acid 7-dehydroxylation: history, biochemistry, and microbiology. | J Lipid Res | 2023 | 37211250 | PubTator, text mining | PubMed |
| Network pharmacology- and molecular docking-based investigation of the therapeutic potential and mechanism of daucosterol against multiple myeloma. | Transl Cancer Res | 2023 | 37180669 | PubTator, text mining | PubMed |
| Editorial: Role of matrix metalloproteinases and other inflammatory mediators in the disruption of the intestinal tight junction barrier. | Front Immunol | 2023 | 37180145 | PubTator, text mining | PubMed |
| Phospholipids, the Masters in the Shadows during Healing after Acute Myocardial Infarction. | Int J Mol Sci | 2023 | 37176067 | PubTator, text mining | PubMed |
| Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer. | Int J Mol Sci | 2023 | 37175811 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy? | Front Oncol | 2023 | 37168385 | PubTator, text mining | PubMed |
| Modulating sphingosine 1-phosphate receptor signaling skews intrahepatic leukocytes and attenuates murine nonalcoholic steatohepatitis. | Front Immunol | 2023 | 37153573 | PubTator, text mining | PubMed |
| Alleviating early demyelination in ischaemia/reperfusion by inhibiting sphingosine-1-phosphate receptor 2 could protect visual function from impairment. | Brain Pathol | 2023 | 37142391 | PubTator, text mining | PubMed |
| Sphingosine-1-phosphate and its receptors in vascular endothelial and lymphatic barrier function. | J Biol Chem | 2023 | 37142226 | PubTator, text mining | PubMed |
| G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. | Signal Transduct Target Ther | 2023 | 37137892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9294/papers?page=13